Phase II, randomized, parallel-cohort study of neoadjuvant buparlisib (BKM120) in combination with trastuzumab and paclitaxel in women with HER2-positive, PIK3CA mutant and PIK3CA wild-type primary breast cancer - NeoPHOEBE Meeting Abstract
| Authors: | Loi, S.; Loibl, S.; Di Cosimo, S.; Nekljudova, V.; Flamen, P.; Saini, K. S.; Michiels, S.; de la Pena, L.; Nanni, S.; Urban, P.; Piccart, M.; von Minckwitz, G.; Baselga, J. |
| Abstract Title: | Phase II, randomized, parallel-cohort study of neoadjuvant buparlisib (BKM120) in combination with trastuzumab and paclitaxel in women with HER2-positive, PIK3CA mutant and PIK3CA wild-type primary breast cancer - NeoPHOEBE |
| Meeting Title: | 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2013 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209496900072 |
| DOI: | 10.1158/0008-5472.sabcs13-ot2-6-08 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OT2-6-08 -- Source: Wos |
